Early diagnosis of AE allows for aggressive treatment, which greatly improves recovery outcomes. On the contrary, delayed diagnosis and treatment can lead to permanent brain injury or even loss of life. In literature, no work has been published which compares clinical, radiological and laboratory characteristics of patients with definite autoantibody-positive AE (AE+) and autoantibody-negative AE (AE-). […]
Antibodies against glutamic-acid-decarboxylase 65 (anti-GAD65) are associated with several neurologic syndromes, including stiff person syndrome and limbic encephalitis. However, their pathogenic role remains controversial. A group led by Dr. Maarten Titulaer (Erasmus University, the Netherlands) studied the clinical relevance of different anti-GAD65 concentrations in patients with neurological disorders and their response to treatment. The group […]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824142/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086669/
https://www.ncbi.nlm.nih.gov/pubmed/22411108
https://www.omicsonline.org/open-access/hyponatremia-and-voltage-gated-potassium-channel-antibody-associated-limbic-encephalitis-2155-9562-5-195.php?aid=24048
https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0035-1552625
http://www.seizure-journal.com/article/S1059-1311(15)00120-X/fulltext
https://www.hindawi.com/journals/ad/2016/9450452/
https://www.sciencedirect.com/science/article/pii/S156899721630163X